ArticleBritish journal of cancer2018

STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer.

Abdi Ghaffari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.